Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanercept

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-3083|31|12|e518-e519

ISSN： 0926-9959

Source： JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.31, Iss.12, 2017-12, pp. : e518-e519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab‐treated patients with psoriasis in a clinical‐practice setting

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 855-857

John Wiley & Sons Inc

Access to resources Recommend Favorite

The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab‐treated patients with psoriasis in a clinical‐practice setting

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 855-857

John Wiley & Sons Inc

Access to resources Recommend Favorite

Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1576-1581

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: restoring therapeutic infliximab drug levels in patients with loss of response—pharmacokinetics and anti‐drug antibodies as useful guidance tools

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 845-846

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: addition of azathioprine to infliximab maintenance therapy in patients with anti‐drug antibodies and subclinical inflammation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 544-545

John Wiley & Sons Inc

Access to resources Recommend Favorite